Concepedia

Author

David P. Rooker

Chilworth Technology (United Kingdom)

Also Known As

D. P. ROOKER, D.P. Rooker, David P Rooker, David P. Rooker, David Rooker, Rooker, D.P.

13

Publications

264

Citations

7

H-Index

19

Concepts

All Affiliations

Chilworth Technology (United Kingdom)
DP

About

David P. Rooker is an author at Chilworth Technology (United Kingdom) specializing in pharmacotherapy, drug discovery, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

200

2

Biochemistry

2

2

88

3

Endocrinology

2

2

52

4

Natural Sciences

1

1

73

5

Gastroenterology

1

1

73

David P. Rooker

×

6

Publications

200

Citations

6

H-Index

YearCitations

(3<i>R</i>)-<i>N</i>-(1-(<i>tert</i>-Butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1<i>H</i>- 1,4-benzodiazepin-3-yl)-<i>N</i>‘-(3-(methylamino)phenyl)urea (YF476):  A Potent and Orally Active Gastrin/CCK-B Antagonist

Graeme Semple, Hamish Ryder, David P. Rooker,

Journal of Medicinal Chemistry

1997

73

New Benzylureas as a Novel Series of Potent, Nonpeptidic Vasopressin V2 Receptor Agonists

Christopher Yea, Christine E. Allan, Doreen M. Ashworth,

Journal of Medicinal Chemistry

2008

37

Peptidomimetic aminomethylene ketone inhibitors of interleukin-1β-converting enzyme (ICE)

Graeme Semple, Doreen M. Ashworth, Andrzej R. Batt,

Bioorganic & Medicinal Chemistry Letters

1998

30

PYRIDONE-BASED PEPTIDOMIMETIC INHIBITORS OF INTERLEUKIN-1β-CONVERTING ENZYME (ICE)

Graeme Semple, Doreen M. Ashworth, Graham R. Baker,

Bioorganic & Medicinal Chemistry Letters

1997

30

Novel cholecystokinin receptor ligands: Oxopiperazines derived from Boc-CCK-4

Andrzej R. Batt, David A. Kendrick, Elizabeth A. Mathews,

Bioorganic & Medicinal Chemistry Letters

1994

15

Nonpeptide oxytocin agonists

Doreen M. Ashworth, A.R. Batt, Andrew Baxter,

Drugs of the Future

2006

15

Page 1